Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.32 |
| ▸ | FNTA | P49354 | 3/20 | 0.32 |
| ▸ | FNTB | P49356 | 3/20 | 0.32 |
| ▸ | GNPAT | O15228 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.32 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.32 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
| ▸ | GART | P22102 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22044568 | 0.82 | PTGS1 (0.36) | NPSR1FNTAFNTBITGB3ITGA2B | |
| SCHEMBL22044504 | 0.79 | PTGS1 (0.46) | NPSR1C3AR1FNTAFNTBGNPAT | |
| SCHEMBL21727091 | 0.78 | FAAH (0.43) | SLC6A5 | |
| SCHEMBL18626096 | 0.77 | NOD1 (0.40) | NOD1SLC6A5FOLH1 | |
| SCHEMBL22388826 | 0.77 | NOD1 (0.39) | NPSR1NOD1SLC6A5 | |
| SCHEMBL21153657 | 0.76 | EPHX2 (0.42) | NPSR1FNTAFNTB | |
| SCHEMBL23583708 | 0.76 | MEN1 (0.45) | NPSR1 | |
| SCHEMBL22843961 | 0.75 | PTGS1 (0.32) | — | |
| SCHEMBL18402748 | 0.75 | PTGS1 (0.46) | — | |
| SCHEMBL20442394 | 0.74 | ALDH1A1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020258893-A1 | A FORMULATION OF A CONJUGATE OF A TUBULYSIN ANALOG TO A CELL-BINDING MOLECULE | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2020-12-30 | — | — | WO | disclosed |